JP2014531897A5 - - Google Patents

Download PDF

Info

Publication number
JP2014531897A5
JP2014531897A5 JP2014528847A JP2014528847A JP2014531897A5 JP 2014531897 A5 JP2014531897 A5 JP 2014531897A5 JP 2014528847 A JP2014528847 A JP 2014528847A JP 2014528847 A JP2014528847 A JP 2014528847A JP 2014531897 A5 JP2014531897 A5 JP 2014531897A5
Authority
JP
Japan
Prior art keywords
variant
seq
amino acid
endostatin
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014528847A
Other languages
English (en)
Japanese (ja)
Other versions
JP6336389B2 (ja
JP2014531897A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2012/081210 external-priority patent/WO2013034116A1/zh
Publication of JP2014531897A publication Critical patent/JP2014531897A/ja
Publication of JP2014531897A5 publication Critical patent/JP2014531897A5/ja
Application granted granted Critical
Publication of JP6336389B2 publication Critical patent/JP6336389B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014528847A 2011-09-09 2012-09-10 Atp結合部位に変異を有するエンドスタチン変異体 Active JP6336389B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201110280441 2011-09-09
CN201110280441.8 2011-09-09
PCT/CN2012/081210 WO2013034116A1 (zh) 2011-09-09 2012-09-10 对atp结合位点进行突变的血管内皮抑制素突变体

Publications (3)

Publication Number Publication Date
JP2014531897A JP2014531897A (ja) 2014-12-04
JP2014531897A5 true JP2014531897A5 (OSRAM) 2015-11-05
JP6336389B2 JP6336389B2 (ja) 2018-06-06

Family

ID=47831548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014528847A Active JP6336389B2 (ja) 2011-09-09 2012-09-10 Atp結合部位に変異を有するエンドスタチン変異体

Country Status (9)

Country Link
US (1) US10647968B2 (OSRAM)
EP (1) EP2754718B1 (OSRAM)
JP (1) JP6336389B2 (OSRAM)
CN (2) CN117987505A (OSRAM)
AU (1) AU2012306826B2 (OSRAM)
CA (1) CA2848118C (OSRAM)
IL (1) IL231419A0 (OSRAM)
RU (1) RU2014113924A (OSRAM)
WO (1) WO2013034116A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104926933B (zh) * 2014-03-19 2018-09-07 北京仁和天通生物科技有限公司 Endostatin突变体、Endostatin突变体与聚乙二醇的交联物以及它们的应用
CN114558111A (zh) * 2014-11-03 2022-05-31 清华大学 一种抑制脂肪细胞分化和胰岛素耐受的药物
JP6896636B2 (ja) * 2015-02-13 2021-06-30 清華大学Tsinghua University 組換えタンパク質薬の分子設計
CN110498851B (zh) * 2015-11-10 2022-10-11 孙嘉琳 一种抗肿瘤蛋白内皮抑素的衍生物及应用
JP7140454B2 (ja) * 2016-11-10 2022-09-21 ベイジン プロトゲン リミテッド ペグ化エンドスタチン類似体およびその適用
JP7492687B2 (ja) * 2017-07-30 2024-05-30 清華大学 Dna-pkcsを阻害するための薬物治療
CN114645025B (zh) * 2022-04-13 2023-12-22 南开大学 一种人源atp合成酶的纯化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1284134A (zh) * 1997-12-08 2001-02-14 贝斯以色列护理医疗中心 利用毕赤氏酵母表达系统生产抗生血管蛋白质∶制管张素,内抑制素或静息蛋白的方法
AU4982200A (en) * 1999-05-06 2000-11-21 Burnham Institute, The Antiangiogenic endostatin peptides, endostatin variants and methods of use
CN1237072C (zh) 2000-05-22 2006-01-18 烟台荣昌生物工程有限公司 生产内皮抑制素的方法
JP4511108B2 (ja) * 2002-05-31 2010-07-28 オンコリクス インコーポレイテッド ヒトプロラクチン拮抗剤−血管新生阻害剤融合蛋白質
CN100475270C (zh) 2006-01-20 2009-04-08 清华大学 一种治疗肿瘤的药物及其应用
CN101143894A (zh) * 2007-06-22 2008-03-19 中国药科大学 高效抑制血管生成多肽及其物理化学修饰方法和应用
EP2270055A4 (en) 2008-04-04 2011-06-29 Procell Therapeutics Inc CELLPERMEABLE RECOMBINANT ENDOSTATINE PROTEIN, POLYNUCLEOTIDE FOR ITS CODING AND ANTICIPATED PREPARATION WITH THE PROTEIN AS AN ACTIVE SUBSTANCE
CN101256139A (zh) 2008-04-18 2008-09-03 山东先声麦得津生物制药有限公司 一种血管内皮抑制素生物活性的检测方法
CN101890155B (zh) * 2010-05-25 2012-07-25 江苏先声药物研究有限公司 一种药物组合物及其应用

Similar Documents

Publication Publication Date Title
ES2667558T3 (es) Polipéptidos de fusión que comprenden una proteína activa unida a un polipéptido con dominio mucina
Rai Peptide and protein mimetics by retro and retroinverso analogs
Olgeiser et al. The key protein of endosomal mRNP transport Rrm4 binds translational landmark sites of cargo mRNAs
Gautam et al. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides
JP2013027391A5 (OSRAM)
WO2011157713A4 (en) Cell-penetrating peptides and uses therof
JP5951509B2 (ja) 免疫グロブリンGFc領域結合ポリペプチド
KR20220105157A (ko) 스플릿 인테인 시스템을 사용하는 단백질 정제
HUE031800T2 (en) Modified Stefin A framework proteins
Jung et al. Two-step chromosome segregation in the stalked budding bacterium Hyphomonas neptunium
JP6504175B2 (ja) レアアース材料結合ペプチド及びその利用
JP6495927B2 (ja) Hgf受容体に結合するアプタマー
Naik et al. Different roles of cell surface and exogenous glycosaminoglycans in controlling gene delivery by arginine-rich peptides with varied distribution of arginines
Rajendran et al. Interaction between the replicase proteins of Tomato bushy stunt virus in vitro and in vivo
RU2014113924A (ru) Мутанты эндостатина с мутациями в сайтах связывания атф
JP2008545393A5 (OSRAM)
JP2008529486A5 (OSRAM)
TW201309720A (zh) 胜肽庫
WO2018170362A4 (en) Versatile display scaffolds for proteins
CN115850507B (zh) 一种正交、双组份蛋白质自组装偶联体系及其构建方法
JP6515486B2 (ja) レアアース種捕捉材料及びその利用
KR101755266B1 (ko) Tale을 포함하는 질환 검출 또는 진단용 조성물
JP2013509200A (ja) 抗体模倣足場
Basu et al. Intein based bioprocess for production of a synthetic antimicrobial peptide: an alternative route to solid phase peptide synthesis
CN114375333B (zh) 包含赖氨酰氧化酶的前肽的组合物及其用途